Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Novo Nordisk Stock Sank 5.6% Today

TheMotleyFool

0 0

Shares of Novo Nordisk (NYSE: NVO) fell on Monday, finishing down 5.6%. The drop comes as the S 500 and the Nasdaq Composite gained 1.5% and 2.6%, respectively.

The Danish drugmaker's stock slumped after the company announced that a Phase II trial had failed to show positive results.

Novo had been testing whether semaglutide, the key ingredient in its blockbuster diabetes and weight loss drugs, could be used to treat Alzheimer's disease.

Source Fool.com

Like: 0

NVO

Share